Renal artery clipping attenuates the progression of adriamycin nephropathy

American Journal of Hypertension

Volumn 11, Issue 9, 1998, Pages 1124-1128

  Balbi, Andre L ^a   Franco, Roberto J S ^a   Barretti, Pasqual ^a   Gavras, Irene ^b   Gavras, Haralambos ^b,c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Adriamycin; Adriamycin nephropathy; Progression of nephropathy; Renal hypoperfusion; Two kidney one clip hypertension

Indexed keywords

4 AMINOHIPPURIC ACID; DOXORUBICIN; INULIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FUNCTION TEST; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DOXORUBICIN; HYPERTENSION, RENOVASCULAR; KIDNEY; KIDNEY DISEASES; MALE; RATS; RATS, WISTAR; RENAL ARTERY;

EID: 0032167442     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00119-8     Document Type: Article

References (22)

1. 1. Bertani T, Poggi A, Pozzoni R, et al: ADR-induced nephrotic syndrome in rats sequence of pathologic events. Lab Invest 1982;46:16-23.
2. 2. Bertani T, Rocchi G, Sacchi G, Remuzzi G: Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis 1986;7:12-19.
3. 3. Okuda S, Oh Y, Tsuruda H, Onayama K, et al: Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 1986;29:502-510.
4. 4. O'Donnel MP, Michels L, Kasiske B, Raij L, et al: Adriamycin-induced chronic proteinuria: a structural and functional study. J Lab Clin Med 1985;106:62-67.
5. 5. Fogo A, Yoshida Y, Glick AD, et al: Serial micropuncture analysis of glomerular function in two models of glomerular sclerosis. J Clin Invest 1988;82:322-330.
6. 6. Scholey JW, Miller PL, Rennke HG, Meyer TW: Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy. Kidney Int 1989;36:816-822.
7. 7. Goldblatt H, Lynch J, Hanzal RF, Summerville WW: Studies on experimental hypertension. 1. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934;59:347-379.
8. 8. Schwietzer G, Gertz K-H: Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats. Kidney Int 1979;15:134-143.
9. 9. Steiner RW, Tucker BJ, Gushwa LC, et al: Glomerular hemodynamics in moderate Goldblatt hypertension in the rat. Hypertension 1982;4:51-57.
10. 10. Kimura G, London GM, Safar ME, et al: Glomerular hypertension in renovascular hypertensive patients. Kidney Int 1991;39:966-972.
11. 11. Lohmeier TE, Cowley AW Jr: Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog. Circ Res 1979;44:154-160.
12. 12. Navar LG, Rosivall L: Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics. Kidney Int 1984;25:857-868.
13. 13. Mitchell KD, Navar LG: Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, 2nd ed. Raven Press, New York, 1995, pp 1437-1450.
14. 14. Gellai M, Valtin H: Chronic vascular constrictions and measurements of renal function in conscious rats. Kidney Int 1979;15:419-426.
15. 15. Young DM: Pathologic effects of adriamycin in experimental system. Cancer Chemother 1975;6:159.
16. 16. Podjarny E, Rathaus M, Shapira J, et al: Captopril, but not diltiazem, favorably affects the course of early chronic renal disease in rats. Nephron 1990;55:196-202.
17. 17. Djukanovic L, Susic D, Jouanovic D, et al: Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats. Isr J Med Sci 1994;30:742-746.
18. 18. Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D: Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clin Sci 1996;90:393-401.
19. 19. Barretti P, Viero RM, Soares VA: Effects of dietary protein, angiotensin I converting enzyme and mesangial overload on the progression of adriamycin induced nephropathy. Braz J Med Biol Res 1995;28:39-50.
20. 20. Remuzzi G, Zoja C, Remuzzi A, et al: Low protein diet prevents glomerular damage in adriamycin treated rats. Kidney Int 1985;28:21-27.
21. 21. Beukers JJB, Hoedmaker PJ, Weening JJ: A comparasion of the effects of converting-enzyme inhibition and protein restriction in experimental nephrosis. Lab Invest 1988;59:631-640.
22. 22. Okuda S, Motomura K, Sanai T, et al: Effect of different levels of protein intake on renal deterioration and nutritional state in experimental renal disease. Clin Sci 1987;73:33-39.